NCT01388920View on ClinicalTrials.gov

Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting

PHASE2TerminatedINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

Tesamorelin

DRUG

Placebo

Sponsors

Lead Sponsor

Theratechnologies

All Listed Sponsors

lead

Theratechnologies

INDUSTRY